Digital Pathology Market growth, analaysis and opportunities with key players preferred strategy. Major players profiled in this report include Visiopharm, Digipath Inc., Koninklinje Philips N. V., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem

German Digital Pathology Market Report, published by Allied Market Research, forecasts that the market is expected to garner $58 million by 2022, registering a CAGR of 12.1% during the period 2016 - 2022.Digital Pathology (DP) is an emerging technology in the pathology field, where glass slides are converted into digital images for easy viewing, analysis, storage, and management of the data collected. This advancement will also bring about upgradation of conventional pathology. Thus, the shortage in number of pathologists around the world is addressed by the use of digital pathology, which is the major benefit of this technology.

Need for cost reduction in laboratories, demand for improved patient care, and enhanced operational efficiency is driving the German digital pathology market. Furthermore, accuracy, ease in remote pathological testing along with acceptability from pathologists and laboratories are other factors that majorly drive this market. However, inadequate infrastructure, lack of reimbursement policies and pending market approvals restrain the market growth.

The digital pathology market is segmented based on product, namely whole slide imaging (WSI), image analysis informatics, information management system storage & communication and telepathology. The whole slide imaging (WSI) segment is the highest revenue-generating market among the segments, due to the capability of WSI to convert glass slides into digital slides and making the study of slides convenient for pathologists. This makes it easier for the pathologist to deliver them easily to other pathologist with reduced cost and without any damage.

Get sample copy of the report at :
https://www.alliedmarketresearch.com/request-sample/1724

Recent developments such as product launch of GeminiSEM 300 system by Carl Zeiss, partnership between Glencoe Software and Carl Zeiss to cover the open source Bio-Formats and product development of CD15 Quantifier by VMscope further signify the increase in competition in the German digital pathology industry. These developments are majorly focused on manufacturing digital pathology instruments, thereby positively increasing the market revenue as well as a healthy rivalry among the manufacturers.

Key Findings of the Germany Digital Pathology Market:

•Whole slide imaging is expected to grow significantly by 2022 at a CAGR of 9.5%.

• Information Management System Storage & Communication is expected to be the second highest growing segment, and would grow at CAGR 11.6% during the forecast period.

• Educational Institutes and Hospitals and diagnostic centers together accounted for over one-third share of the total German digital pathology market.

• Pharmaceutical & biotechnology companies is expected to be the highest growing market by end user; growing at a significant CAGR of 14.4% during 2016 to 2022.

For customized report:
https://www.alliedmarketresearch.com/request-for-customization/1724

key players in the market:

• Digipath Inc.
• Koninklinje Philips N. V.
• PerkinElmer Inc.
• Danaher Corporation (Leica Microsystem)
• Nikon Corporation
• Carl Zeiss AG
• Definiens AG
• VMscope GmbH
• microDimensions GmbH.

Table of content:


Chapter: 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segment
1.3 Research methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top winning strategies

3.3 Conventional pathology vs. digital pathology
3.4 Key player positioning, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Use of digital pathology in cancer diagnosis
3.5.1.2 Cost efficiency
3.5.1.3 Ease in transportation
3.5.1.4 High efficiency
3.5.1.5 Efficient analysis
3.5.1.6 System efficiency
3.5.1.7 Efficiency in workflow
3.5.1.8 Diagnosis in remote regions

3.5.2 Restraints

3.5.2.1 Lack of reimbursement
3.5.2.2 Lack of infrastructure in developing economies
3.5.2.3 Resistance towards adoption of digital pathology

3.5.3 Opportunities

3.5.3.1 Rising awareness pertaining to digital pathology
3.5.3.2 Increasing potential of digital pathology

Access full summary of this report at:
https://www.alliedmarketresearch.com/germany-digital-pathology-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.